Ewa Warchol Celinska

Dr. Ewa Warchol Celinska

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
AGAdrien Georges
Adrien Georges
MYMin-Lee Yang
Min-Lee Yang
TBTakiy Berrandou
Takiy Berrandou
MBMark K. Bakker
Mark K. Bakker
ODOzan Dikilitas
Ozan Dikilitas
NBNabila Bouatia-Naji
Nabila Bouatia-Naji
Fibromuscular dysplasia (FMD) is an arteriopathy associated with hypertension, stroke and myocardial infarction, affecting mostly women. We report results from the first genome-wide association meta-analysis of six studies including 1556 FMD cases and 7100 controls. We find an estimate of SNP-based heritability compatible with FMD having a polygenic basis, and report four robustly associated loci (PHACTR1, LRP1, ATP2B1, and LIMA1). Transcriptome-wide association analysis in arteries identifies one additional locus (SLC24A3). We characterize open chromatin in arterial primary cells and find that FMD associated variants are located in arterial-specific regulatory elements. Target genes are broadly involved in mechanisms related to actin cytoskeleton and intracellular calcium homeostasis, central to vascular contraction. We find significant genetic overlap between FMD and more common cardiovascular diseases and traits including blood pressure, migraine, intracranial aneurysm, and coronary artery disease.

1 September 2015 in Journal of the American Society of Hypertension
Verified
Journal Article
Closed access
ECEwa Warchol Celinska
Ewa Warchol Celinska
MSMaria Styczynska
Maria Styczynska
APAleksander Prejbisz
Aleksander Prejbisz
KPKatarzyna Przybylowska
Katarzyna Przybylowska
MCMalgorzata Chodakowska-Zebrowska
Malgorzata Chodakowska-Zebrowska
MBMaria Barcikowska
Maria Barcikowska

31 October 2023 in Polish Heart Journal
Verified
Journal Article
Open access
PDF file
ECEwa Warchol Celinska
Ewa Warchol Celinska
AMAnna Mazurek-Kula
Anna Mazurek-Kula
PGPatrycja Gladysz-Piestrzynska
Patrycja Gladysz-Piestrzynska
MMMaria Maciejewska-Szabelska
Maria Maciejewska-Szabelska
MŻMałgorzata Żuk
Małgorzata Żuk
PHPiotr Hoffman
Piotr Hoffman
The growing number of adults patients after the Fontan operation requires regular surveillance tests in the specialized centers. Evaluation of current practice of care for Fontan patients in Poland based on a multicenter survey. Eight centers were included in the study-5 adult congenital heart disease (ACHD) and 3 pediatric centers for adolescents. To aim for a comparison between the centers and facilitate the interpretation of the results, the Fontan Surveillance Score (FSS) was developed. The higher score is consistent with better care, with a maximum of 19 points. The number of 398 Fontan patients (243 adults and 155 adolescents [age 14-18 years]) was included in the study. The median FSS was 13 points with variability between the centers (interquartile range 7-14 points). Centers providing continuous care from the pediatric period until 18 years of age achieved a higher FSS compared to ACHD centers (median: 14 points vs 12 points, p< 0.001). Most of the patients, both in the ACHD (82.3%) and in pediatric centers (89%), were seen annually and had a physical examination, electrocardiogram, and echocardiogram performed at each visit. However, unsatisfactory utilization of tests identifying the early stages of Fontan circulation failure (cardiopulmonary exercise tests, cardiac magnetic resonance, liver biochemistry and imaging, detection of protein-losing enteropathy) was observed. The results of the study showed that there is no unified surveillance approach for Fontan patients in Poland. The practice of care for adults differs from that of adolescents.

1 January 2013 in Advances in Interventional Cardiology
Verified
Journal Article
Open access
ECEwa Warchol Celinska
Ewa Warchol Celinska
APAleksander Prejbisz
Aleksander Prejbisz
EFElżbieta Florczak
Elżbieta Florczak
JKJacek Kądziela
Jacek Kądziela
AWAdam Witkowski
Adam Witkowski
AJAndrzej Januszewicz
Andrzej Januszewicz
Clinical trials have demonstrated that catheter-based renal denervation (RDN) reduces blood pressure and improves blood pressure control in patients with resistant hypertension. The follow-up data indicate that the blood pressure lowering effect of the procedure may last for up to 36 months....

20 April 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
AGAdrien Georges
Adrien Georges
MYMin-Lee Yang
Min-Lee Yang
TBTakiy Berrandou
Takiy Berrandou
MBMark K. Bakker
Mark K. Bakker
ODOzan Dikilitas
Ozan Dikilitas
NBNabila Bouatia-Naji
Nabila Bouatia-Naji

14 November 2021 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
ECEwa Warchol Celinska
Ewa Warchol Celinska
APAleksander Prejbisz
Aleksander Prejbisz
PDPiotr Dobrowolski
Piotr Dobrowolski
EWEwa Wypasek
Ewa Wypasek
JKJacek Kądziela
Jacek Kądziela
AJAndrzej Januszewicz
Andrzej Januszewicz